hypogonadism

Panelists: Dr. Abraham Morgentaler Dr. Mohit Khera Dr. Martin Miner

In this episode of Fertility and Other F Words, Dr. Amy Pearlman and Dr. Larry Lipshultz sit down with Mohit Khera for a candid, practical discussion on testosterone and erectile function. Dr. Khera is a board-certified urologist at Baylor College of Medicine, where he holds the F. Brantley...

Stop wasting your time on those kiddie forums, Nelson's house is where it's at! Dr. Omer Raheem Agenda Conclusions

In this SCCR Science Series session, Elaine Costa, MD, a postdoctoral scholar in the Department of Otolaryngology, Head, and Neck Surgery (OHNS) provides an overview of obstructive sleep apnea (OSA). Here she covers:

* Enclomiphene is one of two stereoisomers of clomiphene, the other being Zuclomiphene. Whilst zuclomiphene is more oestrogenic, enclomiphene is more anti-oestrogenic. Zuclomiphene is generally antigonadotropic due to its effects on oestrogen receptors, which leads to a subsequent reduction in...

Great presentation by the leading expert in the field! Abraham Morgentaler For 80 years the question has been: Wrong question The right question: Conclusions

Reframing risk

Professor Alan Rogol

Professor Michael Zitzmann Testosterone Deficiency (TD). and its Effects https://www.excelmale.com/threads/the-male-hormone-reset-how-glp-1ras-lifestyle-and-testosterone-transform-obesity-linked-problems.33386/

Are men going through their own version of menopause? In this episode of MAN ALIVE, NHS GP and leading men's health specialist Dr Jeff Foster breaks down everything you need to know about testosterone: what it is, why levels are falling, how it affects mood, sex drive, strength, motivation and...

How often should men on TRT check their hematocrit? The standard monitoring schedule includes a baseline CBC before starting TRT, a recheck at 3 to 6 weeks, another at 3 months, and then at 6 and 12 months once stable. Any dose or formulation change resets the monitoring clock, requiring a...

Hitting the nail on the head here! * More than 30 years later, he argues that the regulatory framework no longer reflects current clinical evidence and may be doing more harm than good. In this episode, Arundhati Parmar interviews Shalin Shah, CEO of Marius Pharmaceuticals, about...

DEBATE: WHAT IS A LOW TESTOSTERONE? Professor Geoffrey Hackett Professor Shalender Bhasin Synthesis

Dr. Janine Davis Overview Conclusion